Sugammadex – Amomed®
Authorisation EU/1/22/1708/001 · Aop Orphan Pharmaceuticals GmbH
- Licence holder
- Aop Orphan Pharmaceuticals GmbH (all products →)
- Active substance
- Sugammadex sodium
- Clinical trials
- 5 clinical trials →
- Dosage form
- Solution for injection
- Route of administration
- Intravenous use
- ATC code
- V03AB35
- First authorised
- 10/01/2023
- Prescription status
- Product subject to prescription which may not be renewed (A)
- Supply
- Supply through pharmacies only
- Legal basis
- Generic application (Article 10(1) of Directive No 2001/83/EC)
Sugammadex sodium: supply and approvals
19 authorised products on the HPRA list contain Sugammadex sodium. Shortage records below are for the substance in the EU, US and German markets and may not affect this Irish product; for Irish supply, check with the HPRA or a pharmacist.
- EU shortage (EMA)
- No entry in the EMA shortage catalogue (checked 21 Nov 2026)
- US shortage (FDA)
- No entry in the FDA drug shortage list (checked 21 Nov 2026)
- Germany (BfArM)
- 1 supply notice, e.g. Sugammadex Fresenius Kabi (9 Nov 2026 to 25 Jan 2027)
Registers: EU shortages · US shortages · German shortages · EMA approvals
About this licence
Centralised EU authorisation. This product holds an EU-wide marketing authorisation granted by the European Commission after assessment by the European Medicines Agency, valid in every EU country. Its EU product number is 1708. It has been authorised for 3 years (since 10 January 2023). The HPRA list does not say whether it is on sale.
Other medicines with Sugammadex sodium in Ireland
15 other products on the HPRA list contain Sugammadex sodium, from 14 licence holders; 5 of them are marked as marketed. Products with the same substance can differ in strength, form, other ingredients and what they are licensed for, so they are not automatically interchangeable.
| Medicine | Licence holder | Licence | Status |
|---|---|---|---|
| Sugammadex 100 mg/ml solution for injection | AS Kalceks | National authorisation (PA) | Marketed |
| Sugammadex Aspen 100 mg/mL solution for injection | Aspen Pharma Trading Limited | National authorisation (PA) | Marketed |
| Sugammadex Clonmel 100 mg/ml solution for injection | Clonmel Healthcare Ltd | National authorisation (PA) | Marketed |
| Sugammadex Juta 100 mg/ml solution for injection | Juta Pharma GmbH | National authorisation (PA) | Marketed |
| Sugammadex Teva 100 mg/ml solution for injection | Teva B.V. | National authorisation (PA) | Marketed |
| Sugammadex 10 mg/ml solution for injection in pre-filled syringe | Laboratoire Aguettant | National authorisation (PA) | Not marketed |
| Sugammadex 100 mg/mL solution for injection | MSN Labs Europe Limited | National authorisation (PA) | Not marketed |
| Sugammadex 100 mg/ml Solution for Injection | Baxter Holding B.V. | National authorisation (PA) | Not marketed |
| Sugammadex 100 mg/ml Solution for injection | Noridem Enterprises Limited | National authorisation (PA) | Not marketed |
| Sugammadex 100 mg/ml solution for injection | Tamarang S.A. | National authorisation (PA) | Not marketed |
| Sugammadex 50 mg/ml solution for injection in pre-filled syringe | Laboratoire Aguettant | National authorisation (PA) | Not marketed |
| Sugammadex Accord 100 mg/mL solution for injection | Accord Healthcare Ireland Ltd. | National authorisation (PA) | Not marketed |
The licence holder
Aop Orphan Pharmaceuticals GmbH holds 3 products on the HPRA list, with 2 different active substances; 0 of the products are marked as marketed.
This listing is regulatory information, not medical advice — consult the package leaflet, SPC, or a healthcare professional. For the authoritative record see the HPRA register.
How this page is built
The facts on this page are pulled directly from the HPRA's (Health Products Regulatory Authority) official open dataset — they are not written from memory, and nothing here is summarised or edited. Each field below names the dataset it came from, so you can check it yourself.
- HPRA Authorised Medicines List (open data) ↗ Licence number, holder, active substance(s), dosage form, route, ATC code(s), authorisation date and prescription status for this product
This page is built automatically: a daily sync job downloads HPRA's published XML export and copies the licence number, holder, active substance(s), dosage form, route, ATC code(s), authorisation date and prescription status directly into this page — no AI drafting and no per-product editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The HPRA data on this page was last retrieved on 22 Nov 2026. How every register is built: methodology · fixes we have made: corrections log.